Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Sorrento Therapeutics is focused on the development of proprietary drugtherapeutics for addressing unmet medical needs.
Founded
2006
Raised
$150M
Follow us
Alexa global traffic share
Latest funding
$150,000,000
Post-IPO equity - 2016
Ally Bridge Group
Team Size
1–10
Employees
$150,000,000 Post-IPO equity
AVCJ

Ally Bridge leads $150m round for US cancer treatment firm